Literature DB >> 264689

Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.

A M Nigen, J M Manning.   

Abstract

Concentrations of DL-glyceraldehyde between 5 and 20 mM reduce the sickling of S/S erythrocytes even in the complete absence of oxygen; at 10 mM glyceraldehyde the increase in the number of normal cells ranges from 20 to 40%. The inhibition of sickling was both concentration- and time-dependent and was not reversed by repeated washings with buffer. Incubation of erythrocytes with increasing concentrations of glyceraldehyde resulted in only a small increase in the oxygen affinity, a moderate reduction in the Hill coefficient, a substantial increase in the minimum gelling concentration, and modification of up to two lysine residues per hemoglobin molecule.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 264689      PMCID: PMC393262          DOI: 10.1073/pnas.74.1.367

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  On the nature of the transaldolase-dihydroxyacetone complex.

Authors:  B L HORECKER; S PONTREMOLI; C RICCI; T CHENG
Journal:  Proc Natl Acad Sci U S A       Date:  1961-12-15       Impact factor: 11.205

2.  The Amadori rearrangement.

Authors:  J E HODGE
Journal:  Adv Carbohydr Chem       Date:  1955

3.  The mechanism by which glyceraldehyde inhibits glycolysis.

Authors:  H A LARDY; V D WIEBELHAUS; K M MANN
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

4.  Evaluation of sickle hemoglobin and desickling agents by falling ball viscometry.

Authors:  N V Paniker; I Ben-Bassat; E Beutler
Journal:  J Lab Clin Med       Date:  1972-08

5.  Chemical modifications that inhibit gelation of sickle hemoglobin.

Authors:  R Benesch; R E Benesch; S Yung
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  Selective cancer growth inhibition in mice by dihydroxypropanal without concomitant inhibition of bone marrow or other normal tissue.

Authors:  M A Apple; F C Ludwig; D M Greenberg
Journal:  Oncology       Date:  1970       Impact factor: 2.935

7.  Organic phosphate groups in native and borohydride-reduced aldolase.

Authors:  K Kobashi; C Y Lai; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1966-11       Impact factor: 4.013

8.  A new N-terminal blocking group involving a Schiff base in hemoglobin AIc.

Authors:  W R Holmquist; W A Schroeder
Journal:  Biochemistry       Date:  1966-08       Impact factor: 3.162

9.  The reduction of glyceraldehyde by human erythrocytes. L-hexonate dehydrogenase activity.

Authors:  E Beutler; E Guinto
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  8 in total

1.  Some factors that influence the nonenzymatic glycation of peptides and polypeptides by glyceraldehyde.

Authors:  Y Bai; H Ueno; J M Manning
Journal:  J Protein Chem       Date:  1989-04

2.  Use of citrate agar electrophoresis in evaluation of antisickling agents.

Authors:  E Wilson; W P Winter
Journal:  J Natl Med Assoc       Date:  1981-02       Impact factor: 1.798

3.  Reaction of glycolaldehyde with proteins: latent crosslinking potential of alpha-hydroxyaldehydes.

Authors:  A S Acharya; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Antisickling activity of amino acid benzyl esters.

Authors:  M Gorecki; C T Acquaye; M Wilchek; J R Votano; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

5.  Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin A: preferential inhibition of glycation by nucleophiles at sites of low isomerization potential.

Authors:  A S Acharya; R P Roy; B Dorai
Journal:  J Protein Chem       Date:  1991-06

6.  Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.

Authors:  J A Walder; R H Zaugg; R S Iwaoka; W G Watkin; I M Klotz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.

Authors:  A M Nigen; J M Manning
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

8.  Inhibition of erythrocyte sickling in vitro by pyridoxal.

Authors:  J A Kark; M P Kale; P G Tarassoff; M Woods; L S Lessin
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.